| Q46265580 | Acetylation Regulates Thioredoxin Reductase Oligomerization and Activity. |
| Q24297014 | An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling |
| Q36544467 | B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy |
| Q33326607 | Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells |
| Q84007969 | Changes in the expression of selenoproteins in mesial temporal lobe epilepsy patients |
| Q93164485 | Coenzyme Q10 Supplementation in Fibrosis and Aging |
| Q64096823 | Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging |
| Q28510029 | Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development |
| Q64080820 | Decrease in inflammatory biomarker concentration by intervention with selenium and coenzyme Q10: a subanalysis of osteopontin, osteoprotergerin, TNFr1, TNFr2 and TWEAK |
| Q42755576 | Diphenyl diselenide potentiates nephrotoxicity induced by mercuric chloride in mice |
| Q44600366 | Effect of selenium and Q10 on the cardiac biomarker NT-proBNP. |
| Q33628551 | Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability |
| Q50493191 | Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand. |
| Q42446471 | Effects of the antioxidant Pycnogenol on cellular redox systems in U1285 human lung carcinoma cells. |
| Q35707939 | Extramitochondrial reduction of ubiquinone by flavoenzymes |
| Q36534861 | Glutaredoxin mediated redox effects of coenzyme Q10 treatment in type 1 and type 2 diabetes patients |
| Q47935257 | Improved Health-Related Quality of Life, and More Days out of Hospital with Supplementation with Selenium and Coenzyme Q10 Combined. Results from a Double Blind, Placebo-Controlled Prospective Study |
| Q33801828 | Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay |
| Q40340040 | Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells |
| Q44646961 | Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein |
| Q36856181 | Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni |
| Q41054976 | Less increase of copeptin and MR-proADM due to intervention with selenium and coenzyme Q10 combined: Results from a 4-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens |
| Q35777029 | Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial |
| Q47993837 | Modulation of endogenous antioxidant activity by resveratrol and exercise in mouse liver is age dependent. |
| Q46829418 | Nephroprotective potential of selenium and taurine against mercuric chloride induced nephropathy in rats |
| Q35711019 | Nutrigenetics, nutrigenomics, and selenium. |
| Q40506655 | Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. |
| Q40117504 | Overexpression of thioredoxin reductase 1 inhibits migration of HEK-293 cells. |
| Q51800539 | Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H:paraquat oxidoreductase: identification of the enzyme as thioredoxin reductase. |
| Q36510647 | Protective effects of coenzyme q(10) on decreased oxidative stress resistance induced by simvastatin |
| Q38690806 | Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System. |
| Q35857053 | Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens |
| Q46894751 | Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase |
| Q37086087 | Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation |
| Q38199451 | Selenium and selenoprotein function in brain disorders |
| Q96227780 | Selenium supplementation can relieve the clinical complications of COVID-19 and other similar viral infections |
| Q50192080 | Selenoproteins and cardiovascular stress |
| Q36209216 | Sequence analysis, expression profiles and function of thioredoxin 2 and thioredoxin reductase 1 in resistance to nucleopolyhedrovirus in Helicoverpa armigera |
| Q90420055 | Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population |
| Q33610447 | Significant changes in circulating microRNA by dietary supplementation of selenium and coenzyme Q10 in healthy elderly males. A subgroup analysis of a prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens |
| Q89800067 | Significant decrease of von Willebrand factor and plasminogen activator inhibitor-1 by providing supplementation with selenium and coenzyme Q10 to an elderly population with a low selenium status |
| Q52720052 | Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly. |
| Q36066100 | Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial |
| Q92042830 | The Cell Culture Medium Affects Growth, Phenotype Expression and the Response to Selenium Cytotoxicity in A549 and HepG2 Cells |
| Q28607038 | The WOMED model of benign thyroid disease: Acquired magnesium deficiency due to physical and psychological stressors relates to dysfunction of oxidative phosphorylation |
| Q35547196 | The conserved Trp114 residue of thioredoxin reductase 1 has a redox sensor-like function triggering oligomerization and crosslinking upon oxidative stress related to cell death |
| Q38828101 | The expression and activity of thioredoxin reductase 1 splice variants v1 and v2 regulate the expression of genes associated with differentiation and adhesion |
| Q35675195 | The level of menadione redox-cycling in pancreatic β-cells is proportional to the glucose concentration: role of NADH and consequences for insulin secretion |
| Q42544721 | The quality control assessment of commercially available coenzyme q(10)-containing dietary and health supplements in Japan |
| Q26829701 | The redox biology of schistosome parasites and applications for drug development |
| Q34274107 | The thioredoxin system—From science to clinic |
| Q35718544 | Therapeutic effects of coenzyme Q10 in neurodegenerative diseases |
| Q28469234 | Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target |
| Q35535825 | Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases. |
| Q34416920 | Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity |
| Q37244871 | Thioredoxin reductase was nitrated in the aging heart after myocardial ischemia/reperfusion |
| Q50666202 | Transcriptional profiling of pig embryogenesis by using a 15-K member unigene set specific for pig reproductive tissues and embryos. |